RE: Views9 Apr 2021 16:04
Hopefully Sunday night or next week we hear from Craig for a little bit of transparency. If there’s nothing to report, that’s fine but reminding investors to check out its latest presentation. In this presentation it states how they’re funded up until and potentially beyond 2023 with £4m. Yesterday this was posted by them, less than 24 hours later, a 10% dillution and placing for 90,000,000 shares. Not a fan, financials are something investors research and knowing they’re fully funded, could be a factor to have bought into ECR.
Just give us a plan Craig moving forward, even if it looks likely we will be drilling Creswick ourselves. The “I can’t say too much” approach gives us absolutely nothing and watching an interview with him over a year ago, this was his approach then. I can see licensing issues taking a while to be resolved and approved yet.
6 holes drilled at HR3, serious potential to be extract value from Bailleston this year. It’s not a “must”, but with close to 6million in the bank and the cost of a drill 170k, it’s a no brainier for me, along with the custom labs being built.
My preference is to hit blue moon again next, get some sentiment back and trust in the investors.as far as the assays go, who knows. It’s clear the company do not have to release this information straight away, I’m hoping they’re building up an RNS of substance. A placing, followed by negative assay results would be a bit of a disaster.
if your still invested here, take a breather, evaluate the company and ask yourself can you still see Bailleston and Creswick going to production in 18-24 months. My answer is yes and it’s why I’m invested,!just need a little clarification of the programme moving forward.